Aptevo Therapeutics Inc. (APVO)

Last Closing Price: 9.29 (2026-01-21)

Earnings Announcements: Estimated vs Actual

On 2025-11-06, Aptevo Therapeutics Inc. (APVO) announced earnings per share of $-40.11 for the fiscal quarter ending 2025-09-30, missing the average analyst estimate of $-37.59.

The next expected annoucement date for quarterly earnings is 2026-02-13, with an average estimated earnings per share of $-8.09 for the fiscal quarter ending 2025-12-31.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.

Announcement Date Fiscal Quarter End Estimated EPS Actual EPS
2025-11-06 2025-09-30 $-37.59 $-40.11
2025-08-11 2025-06-30 -- $-151.08
2025-05-15 2025-03-31 $-1514.39 $-1579.14
2024-11-07 2024-09-30 $-7428.84 $-6255.86
2024-08-08 2024-06-30 $-25153.79 $-21765.20
2024-05-08 2024-03-31 $-183766.03 $-129678.87
2023-11-14 2023-09-30 $-413383.16 $-287071.63
2023-08-10 2023-06-30 $-643040.44 $-706196.19
2023-05-11 2023-03-31 $-683230.50 $149277.23
2022-11-10 2022-09-30 $-941594.88 $-878439.13
2022-08-11 2022-06-30 $-763610.50 $-1067906.38
2022-05-12 2022-03-31 $-660264.69 $-912887.75
2021-11-12 2021-09-30 $-849732.00 $-832507.69
2021-08-12 2021-06-30 $-1119579.38 $-1021974.94
2021-05-11 2021-03-31 $-930112.06 $-999009.25
2020-11-10 2020-09-30 $-1176993.63 $-1234408.00
2020-08-14 2020-06-30 $-1303305.13 $-1205700.75
2020-05-13 2020-03-31 $-1464065.25 $-1389426.63
2019-11-07 2019-09-30 $-1929893.13 $-1849481.00
2019-08-09 2019-06-30 $-3055664.00 $-2412366.50
2019-05-09 2019-03-31 $-3859786.25 $-3538137.50
2018-11-14 2018-09-30 $-4744320.50 $-4503084.00
2018-08-09 2018-06-30 $-5226793.50 $-4663908.50
2018-05-10 2018-03-31 $-4503084.00 $-5065969.50
2017-11-09 2017-09-30 $9999999.99 $1125771.00
2017-08-10 2017-06-30 -- $-4261847.00
2017-05-12 2017-03-31 $-5709267.00 $-3859786.25
2017-03-31 2016-12-31 -- $80412.21
2016-11-14 2016-09-30 $-5146381.50 $-6432977.00
2016-08-25 2016-06-30 -- $-5065969.50